Biofluid diagnostics by FTIR spectroscopy: A platform technology for cancer detection

Sala, Alexandra, Anderson, David J, Brennan, Paul M, Butler, Holly J, Cameron, James M, Jenkinson, Michael D ORCID: 0000-0003-4587-2139, Rinaldi, Christopher, Theakstone, Ashton G and Baker, Matthew J (2020) Biofluid diagnostics by FTIR spectroscopy: A platform technology for cancer detection. CANCER LETTERS, 477. pp. 122-130.

Text v2_DRAFT_MiniReview_CancerLetters-mdj.docx - Author Accepted Manuscript Download (3MB)

Abstract

Fourier Transform Infrared Spectroscopy (FTIR) has been largely employed by scientific researchers to improve diagnosis and treatment of cancer, using various biofluids and tissues. The technology has proved to be easy to use, rapid and cost-effective for analysis on human blood serum to discriminate between cancer versus healthy control samples. The high sensitivity and specificity achievable during samples classification aided by machine learning algorithms, offers an opportunity to transform cancer referral pathways, as it has been demonstrated in a unique and recent prospective clinical validation study on brain tumours. We herein highlight the importance of early detection in cancer research using FTIR, discussing the technique, the suitability of serum for analysis and previous studies, with special focus on pre-clinical factors and clinical translation requirements and development.

Item Type:	Article
Uncontrolled Keywords:	Infrared spectroscopy, ATR-FTIR, Cancer, Early detection, Biofluids, Serum, Brain tumour
Depositing User:	Symplectic Admin
Date Deposited:	12 May 2020 10:03
Last Modified:	18 Jan 2023 23:52
DOI:	10.1016/j.canlet.2020.02.020
Related URLs:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3086389